Similarly, Talib et al. 2024 found that the IL-17A gene polymorphism was associated with increased IP risk, with higher IL-23 levels contributing to inflammatory processes in peri-implant tissues [17]. This evidence concerns the gene IL17A and incontinentia pigmenti.